{"id":"boostrix-us-formulation","safety":{"commonSideEffects":[{"rate":"40–75","effect":"Injection site pain"},{"rate":"20–40","effect":"Injection site erythema"},{"rate":"20–40","effect":"Injection site swelling"},{"rate":"20–40","effect":"Fatigue"},{"rate":"20–40","effect":"Headache"},{"rate":"10–30","effect":"Myalgia"},{"rate":"5–15","effect":"Fever"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Boostrix contains inactivated toxoids of diphtheria and tetanus, plus acellular pertussis antigens, which trigger adaptive immune responses without causing disease. Upon vaccination, the immune system generates antibodies and cellular immunity against these three bacterial pathogens, providing protection against infection and disease.","oneSentence":"Boostrix is a vaccine that stimulates the immune system to produce antibodies against diphtheria, tetanus, and pertussis (whooping cough) pathogens.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:39:18.998Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Booster immunization against diphtheria, tetanus, and pertussis in adolescents and adults aged 10 years and older"}]},"trialDetails":[{"nctId":"NCT01147900","phase":"PHASE4","title":"Evaluation of Boostrix™10 Years After Previous Booster Vaccination","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2010-06-15","conditions":"Acellular Pertussis, Tetanus, Diphtheria","enrollment":180}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":166775,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Boostrix™-US formulation","genericName":"Boostrix™-US formulation","companyName":"GlaxoSmithKline","companyId":"glaxosmithkline","modality":"Biologic","firstApprovalDate":"","aiSummary":"Boostrix is a vaccine that stimulates the immune system to produce antibodies against diphtheria, tetanus, and pertussis (whooping cough) pathogens. Used for Booster immunization against diphtheria, tetanus, and pertussis in adolescents and adults aged 10 years and older.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}